Showing results (1501-1510 of 1,715) with videos related to

Sort By:
Pageof 172
Biological Reviews of the Cambridge Philosophical Society|September 23, 2014
The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayAnna Stincone, Alessandro Prigione, Thorsten Cramer, et al.
Stem Cells and Development|January 21, 2017
Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous LeukemiaAnna Chorzalska, Javier Flores Kim, Karim Roder, et al.
Nature|August 2, 2019
Lysine harvesting is an antioxidant strategy and triggers underground polyamine metabolismViridiana Olin-Sandoval, Jason Shu Lim Yu, Leonor Miller-Fleming, et al.
Acta Oncologica (Stockholm, Sweden)|June 10, 2021
Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patientsSahar Ahangari, Naja Liv Hansen, Anders Beck Olin, et al.
Journal of the American College of Cardiology|July 9, 2016
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMDDaniella Kadian-Dodov, Heather L Gornik, Xiaokui Gu, et al.
Transplantation and Cellular Therapy|May 3, 2023
The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation PatientsSarah A Wall, Rebecca Olin, Vijaya Bhatt, et al.
Blood Advances|June 24, 2020
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomesRebecca L Olin, Caitrin Fretham, Marcelo C Pasquini, et al.
JAMA Neurology|July 18, 2017
Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular DysplasiaHenry D Lather, Heather L Gornik, Jeffrey W Olin, et al.
JCI Insight|November 8, 2021
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19Suchitra Kamle, Bing Ma, Chuan Hua He, et al.
Leukemia & Lymphoma|October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remissionGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Pageof 172